About Positive Biosciences Limited
Data last updated: 11 February 2026
Positive Biosciences Limited is a public limited company based in Thousand Lights,Chennai 6., Tamil Nadu, India, a subsidiary of Doubledot Finance Limited. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 23 February 1995, the company has been in operation for over 31 years.
Registered with ROC Chennai under CIN U15499TN1995PLC030290.
Capital: an authorised share capital of ₹23.43 Cr and a paid-up capital of ₹23.05 Cr. Formerly known as Sahu Foods Limited and Captain Cook Food Products Limited. It is led by directors including John Antony Dsouza and Riyazuddin Kalimullah Khan.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 645 Anna Salaithousand Lights Chennai 6. Thousand Lights Chennai 6., Tamil Nadu, India – 600006.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.96 Lakh, a decline of 91% compared to the previous year.
The company has a workforce of approximately 10 employees as per the latest available data. It operates as a subsidiary of Doubledot Finance Limited.
The company is associated with 1 brand - Positive Bioscience.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website positivebioscience.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered Address645 Anna Salaithousand Lights Chennai 6. Thousand Lights Chennai 6., Tamil Nadu, India – 600006
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Positive Biosciences Limited
Positive Biosciences Limited has undergone 2 name changes throughout its history. The company was previously known as Sahu Foods Limited, and Captain Cook Food Products Limited. The current legal name is Positive Biosciences Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Positive Biosciences Limited | Current |
| Sahu Foods Limited | Previous |
| Captain Cook Food Products Limited | Previous |
CIN History of Positive Biosciences Limited
Positive Biosciences Limited has one previous CIN (Corporate Identification Number): U15499TN1995PLC030290. The current CIN is U93000TN1995PLC030290, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U93000TN1995PLC030290 | Current |
| U15499TN1995PLC030290 | Previous |
Associated Brands with Positive Biosciences Limited
Positive Biosciences Limited operates one associated brand: Positive Bioscience. These brands represent Positive Biosciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| DNA tests for cancer treatment and hereditary screening are provided. | positivebioscience.com |
Competitors & Alternatives of Positive Biosciences Limited
Brands and companies operating in the same space as Positive Biosciences Limited include Guardant Health, Foundation Medicine, Personalis and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Guardant Health
|
Digital sequencing technology for cancer detection is developed. | Redwood City, United States, United States | 2012 |
Foundation Medicine
|
Genomics-based diagnostic tests for cancer are provided. | Cambridge, United States, United States | 2010 |
Personalis
|
Genomic sequencing and diagnosis software is provided for healthcare. | Menlo Park, United States, United States | 2011 |
Natera
|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | Redwood City, United States, United States | 2004 |
Neogen
|
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | Lansing, United States, United States | 1982 |
Prenetics
|
Health risks are identified through online genetic and diagnostic testing. | Hong Kong, China, China | 2009 |
Parse Biosciences
|
RNA-sequencing transcriptome kits for health data analysis are developed. | Seattle, United States, United States | 2018 |
ArcherDX
|
Molecular cancer diagnostic products are developed using patented AMP technology. | Boulder, United States, United States | 2013 |
Thrive Earlier Detection
|
Blood-based liquid biopsy tests for multiple cancer detection are provided. | Cambridge, United States, United States | 2019 |
Business Activity of Positive Biosciences Limited
Positive Biosciences Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | ********* |
Board of Directors of Positive Biosciences Limited
Positive Biosciences Limited is currently managed by 7 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
John Antony Dsouza
Also directs:
Crescent Finstock Limited, Net Classroom Private Limited
|
Director | 20 Mar 2020 | 6 Years 3 Months | Current |
|
Riyazuddin Kalimullah Khan
Also directs:
Crescent Finstock Limited, Doubledot Finance Limited, Net Classroom Private Limited and 1 more
|
Director | 08 Mar 2022 | 4 Years 4 Months | Current |
| Alwyn Leo Dsouza | Director | 14 Feb 2015 | 11 Years 4 Months | Current |
|
Bharati Nitish Jain
Also directs:
Crescent Finstock Limited, Classic Garden Private Limited, Netmoney Pprivate Limited and 3 more
|
Director | 30 Apr 2019 | 7 Years 2 Months | Current |
| Seema Hitesh Bhavnani | Cfo | 14 Aug 2024 | 1 Years 10 Months | Current |
|
Nitish Jain
Also directs:
Crescent Finstock Limited, Classic Garden Private Limited, Netmoney Pprivate Limited and 1 more
|
Director | 23 Feb 1995 | 31 Years 4 Months | Current |
Financials of Positive Biosciences Limited FY 2025 filings available
Positive Biosciences Limited reported revenue of ₹35.96 Lakh (down 91% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings Positive Biosciences Limited
Positive Biosciences Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Positive Biosciences Limited
View historical data on people associated with Positive Biosciences Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Positive Biosciences Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Positive Biosciences Limited
GSTIN & GST Filing Data of Positive Biosciences Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Positive Biosciences Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Positive Biosciences Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Positive Biosciences Limited
MSME Payment Delays by Positive Biosciences Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Positive Biosciences Limited
Subsidiaries & Group Companies of Positive Biosciences Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Positive Biosciences Limited with ownership details.
MCA Filings & Documents of Positive Biosciences Limited
MCA Filings & Documents of Positive Biosciences Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Positive Biosciences Limited
Frequently Asked Questions about Positive Biosciences Limited
Positive Biosciences Limited is an active public limited company in the life sciences sector based in Thousand Lights,Chennai 6, Tamil Nadu, India. It was incorporated on 23 February 1995 (31+ years old) and is registered under CIN U93000TN1995PLC030290. The company has 10 employees.
Positive Biosciences Limited reported revenue of ₹35.96 Lakh for FY 2025 (down 91.00% YoY).
The current directors of Positive Biosciences Limited are:
The primary industry of Positive Biosciences Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Positive Biosciences Limited can be reached at the registered office: 645 Anna Salaithousand Lights Chennai 6. Thousand Lights Chennai 6, Tamil Nadu, India – 600006, or through the website positivebioscience.com.
The authorised capital is ₹23.43 Cr, and the paid-up capital is ₹23.05 Cr.